Clinical Trials Logo

Clinical Trial Summary

Shoulder arthroscopic causes post operative pain that outlasts analgesia provided by single injection nerve blocks.


Clinical Trial Description

The interscalene brachial plexus block (ISBPB) is a common analgesic technique for procedures of the shoulder and upper arm.

Moreover, the incidence of rebound pain is well documented and is often of considerable discomfort to patients, who may quickly go from little or no pain to moderate-severe pain. Continuous nerve block techniques with home ambulatory catheters are currently utilized to manage postoperative pain.This study is designed to compare the level and duration of pain control of Exparel® injected after bupivacaine via stop-cock connected syringes and bupivacaine alone for ISBPB. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT02554357
Study type Interventional
Source North American Institute for Continuing Medical Education (NAICE)
Contact
Status Completed
Phase N/A
Start date July 2015
Completion date March 2016

See also
  Status Clinical Trial Phase
Withdrawn NCT01538459 - Plasma Glucose Levels With Dexamethasone as Adjuvant to Interscalene Block Phase 3
Active, not recruiting NCT02725320 - Rotator Cuff Surgical Outcomes in Women